Clinical Trial Presented at HRS 2024 Shows Benefits of Early

Clinical Trial Presented at HRS 2024 Shows Benefits of Early Cardiac Resynchronization Therapy (CRT) in Slowing Progression of Heart Failure

A study conducted by researchers at Mayo Clinic, sponsored by the National Heart, Lung, and Blood Institute, found that early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB). The findings were presented during the final day of the Heart Rhythm Society meeting, HRS 2024, being held in Boston, MA.

Related Keywords

United States , Boston , Massachusetts , America , Yong Mei Cha , Heart Rhythm Society , National Heart , Left Bundle Branch Block , Blood Institute , Heart Failure Society Of America , Breaking Clinical Trials , Early Cardiac Resynchronization Therapy , Moderately Reduced Ejection Fraction , Left Bundle Branch , Mayo Clinic , Heart Failure Society ,

© 2025 Vimarsana